| 000 | 01453 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515000729.0 | ||
| 264 | 0 | _c20060127 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0167-6806 | ||
| 024 | 7 |
_a10.1007/s10549-005-7491-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDanforth, David N | |
| 245 | 0 | 0 |
_aConversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cNov 2005 |
||
| 300 |
_a81-91 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTretinoin _xpharmacology |
| 650 | 0 | 4 |
_afas Receptor _xdrug effects |
| 700 | 1 | _aZhu, Yuelin | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 94 _gno. 1 _gp. 81-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-005-7491-6 _zAvailable from publisher's website |
| 999 |
_c15772170 _d15772170 |
||